Select your localized edition:

Close ×

More Ways to Connect

Discover one of our 28 local entrepreneurial communities »

Be the first to know as we launch in new countries and markets around the globe.

Interested in bringing MIT Technology Review to your local market?

MIT Technology ReviewMIT Technology Review - logo

 

Unsupported browser: Your browser does not meet modern web standards. See how it scores »

{ action.text }

Doctors who perform in vitro fertilization typically rely on a visual assessment of the embryos when deciding which ones to transfer into the uterus, but two-thirds of such embryos fail to implant. A new test analyzes the proteins and small-molecule metabolites in the fluid surrounding each embryo and compares the resulting metabolic profile with that of a healthy embryo. The test improves implantation rates up to 30 percent. That means doctors can transfer fewer embryos, reducing the chances of an undesired multiple pregnancy.

Product: ViaMetrics-E
Cost: $30,000 to $50,000 for the testing system in the U.S. market. (Tests will not add appreciably to the typical cost of $12,000 to $15,000 for an IVF treatment.)
Availability: Now in the U.K., Australia, Japan, Ireland, and Greece; seeking FDA approval in the U.S.
Source: www.molecularbiometrics.com
Company: Molecular Biometrics

Credit: Courtesy of Molecular Biometrics

Tagged: Biomedicine

Reprints and Permissions | Send feedback to the editor

From the Archives

Close

Introducing MIT Technology Review Insider.

Already a Magazine subscriber?

You're automatically an Insider. It's easy to activate or upgrade your account.

Activate Your Account

Become an Insider

It's the new way to subscribe. Get even more of the tech news, research, and discoveries you crave.

Sign Up

Learn More

Find out why MIT Technology Review Insider is for you and explore your options.

Show Me